Effectiveness of robot-assisted virtual reality mirror therapy for upper limb motor dysfunction after stroke: study protocol for a single-center randomized controlled clinical trial

• Published in: BMC neurology Vol. 22; no. 1; pp. 1 - 307
• Main Authors: Wei, Dong, Hua, Xu-Yun, Zheng, Mou-Xiong, Wu, Jia-Jia, Xu, Jian-Guang
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 22.08.2022; BioMed Central; BMC
• Subjects: Activities of daily living; Adverse events; Care and treatment; Chinese medicine; Clinical trials; Cognitive ability; Complications and side effects; Data analysis; Functional magnetic resonance imaging; Functional magnetic resonance imaging (fMRI); Health aspects; Hospitals; Intervention; Pain; Patients; Physical therapy; Proprioception; Quality of life; Randomized controlled trial; Rehabilitation; Reinforcement; Robot-assisted virtual reality mirror therapy (RAVRMT); Robots; Stroke; Stroke (Disease); Study Protocol; Therapeutic applications; Therapists; Therapy; Upper limb motor dysfunction; Virtual reality; Visual pathways; China; Canada; Montreal Quebec Canada
• ISSN: 1471-2377; 1471-2377
• DOI: 10.1186/s12883-022-02836-6

Abstract Background Upper limb motor dysfunction is a common sequela of stroke, and its clinical efficacy needs to be improved. This protocol describes a trial to verify the clinical efficacy of robot-assisted virtual reality mirror therapy (RAVRMT) in improving upper limb motor dysfunction in stroke patients, and to explore the central mechanism by using functional magnetic resonance imaging (fMRI). Methods This trial will be a single-center, assessor-blinded, randomized controlled clinical study. Thirty-two eligible patients will be randomly divided into 2 groups according to the ratio of 1:1, namely virtual reality mirror therapy (VRMT) group and robot-assisted virtual reality mirror therapy (RAVRMT) group. The interventions will be performed once a day for 4 weeks. Primary outcome is Fugl–Meyer motor function assessment-Upper Extremity (FMA-UE), secondary outcomes are the Montreal Cognitive Assessment (MoCA), activities of daily living (ADL), quality of life (QOL), the pain visual analogue scale (VAS-pain) and fMRI. Adverse events will be recorded, and severe adverse events will be used as criteria to discontinue the intervention. Discussion Combined application of robot-assisted therapy and virtual reality mirror therapy could theoretically activate mirror neuron system and reward circuits to a greater extent, but further high-quality research is needed. The results of this trial will determine whether RAVRMT could better improve upper limb motor dysfunction after stroke and explore its central mechanism using fMRI. Trial registration This trial was prospectively registered at ClinicalTrials.gov (ChiCTR2200061721; 01 July 2022).